Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition
about
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersDopamine signaling tunes spatial pattern selectivity in C. elegans.Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder.
P2860
Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antianxiety medications for th ...... ons for a behavioral condition
@en
Antianxiety medications for th ...... ns for a behavioral condition.
@nl
type
label
Antianxiety medications for th ...... ons for a behavioral condition
@en
Antianxiety medications for th ...... ns for a behavioral condition.
@nl
prefLabel
Antianxiety medications for th ...... ons for a behavioral condition
@en
Antianxiety medications for th ...... ns for a behavioral condition.
@nl
P2093
P2860
P356
P1476
Antianxiety medications for th ...... ons for a behavioral condition
@en
P2093
Daniela Caldirola
Giampaolo Perna
Roberta Menotti
Silvia Daccò
P2860
P304
P356
10.2147/NDT.S12979
P407
P577
2011-10-19T00:00:00Z